Your browser doesn't support javascript.
loading
Is HLA type a possible cancer risk modifier in Lynch syndrome?
Ahadova, Aysel; Witt, Johannes; Haupt, Saskia; Gallon, Richard; Hüneburg, Robert; Nattermann, Jacob; Ten Broeke, Sanne; Bohaumilitzky, Lena; Hernandez-Sanchez, Alejandro; Santibanez-Koref, Mauro; Jackson, Michael S; Ahtiainen, Maarit; Pylvänäinen, Kirsi; Andini, Katarina; Grolmusz, Vince Kornel; Möslein, Gabriela; Dominguez-Valentin, Mev; Møller, Pål; Fürst, Daniel; Sijmons, Rolf; Borthwick, Gillian M; Burn, John; Mecklin, Jukka-Pekka; Heuveline, Vincent; von Knebel Doeberitz, Magnus; Seppälä, Toni; Kloor, Matthias.
Affiliation
  • Ahadova A; Department of Applied Tumor Biology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Witt J; Cooperation Unit Applied Tumor Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.
  • Haupt S; Department of Applied Tumor Biology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Gallon R; Cooperation Unit Applied Tumor Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.
  • Hüneburg R; Engineering Mathematics and Computing Lab (EMCL), Interdisciplinary Center for Scientific Computing (IWR), Heidelberg University, Heidelberg, Germany.
  • Nattermann J; Data Mining and Uncertainty Quantification (DMQ), Heidelberg Institute for Theoretical Studies (HITS), Heidelberg, Germany.
  • Ten Broeke S; Translational and Clinical Research Institute, Newcastle University, International Centre for Life, Newcastle upon Tyne, UK.
  • Bohaumilitzky L; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.
  • Hernandez-Sanchez A; National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany.
  • Santibanez-Koref M; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.
  • Jackson MS; National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany.
  • Ahtiainen M; Department of Genetics, University Medical Center Groningen, Groningen, The Netherlands.
  • Pylvänäinen K; Department of Applied Tumor Biology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Andini K; Cooperation Unit Applied Tumor Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.
  • Grolmusz VK; Department of Applied Tumor Biology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Möslein G; Cooperation Unit Applied Tumor Biology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.
  • Dominguez-Valentin M; Translational and Clinical Research Institute, Newcastle University, International Centre for Life, Newcastle upon Tyne, UK.
  • Møller P; Translational and Clinical Research Institute, Newcastle University, International Centre for Life, Newcastle upon Tyne, UK.
  • Fürst D; Department of Pathology, Nova Hospital, Jyväskylä, Finland.
  • Sijmons R; Department of Education and science, Nova Hospital, Jyväskylä, Finland.
  • Borthwick GM; Department of Genetics, University Medical Center Groningen, Groningen, The Netherlands.
  • Burn J; Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
  • Mecklin JP; Hereditary Cancers Research Group, Hungarian Academy of Sciences-Semmelweis University, Budapest, Hungary.
  • Heuveline V; Department of Surgery, Ev. Krankenhaus Bethesda Hospital, Duisburg, Germany.
  • von Knebel Doeberitz M; Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, Oslo, Norway.
  • Seppälä T; Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, Oslo, Norway.
  • Kloor M; Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service, Baden Wuerttemberg-Hessen, University Hospital Ulm, Ulm, Germany.
Int J Cancer ; 152(10): 2024-2031, 2023 05 15.
Article in En | MEDLINE | ID: mdl-36214792
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplastic Syndromes, Hereditary / Colorectal Neoplasms / Colorectal Neoplasms, Hereditary Nonpolyposis Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Int J Cancer Year: 2023 Document type: Article Affiliation country: Alemania
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplastic Syndromes, Hereditary / Colorectal Neoplasms / Colorectal Neoplasms, Hereditary Nonpolyposis Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Int J Cancer Year: 2023 Document type: Article Affiliation country: Alemania